PAR 4.76% 20.0¢ paradigm biopharmaceuticals limited..

Current SP appreciation, page-26

  1. 1,683 Posts.
    lightbulb Created with Sketch. 29
    Isn't liquidity also a limitation? I would expect that at some point they will have to do a stock split or keep doing capital raisings to inject more stock into the market to increase liquidity.

    Can anyone more knowledgeable on this confirm? This is in relation to ASX300/200 and fund requirements.
    Last edited by Roamer: 23/09/19
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.